COVID-19 rollout strategy recalibrated

Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.

Pharmacological interventions for managing acute pancreatitis

The prevalence of acute pancreatitis is between 5 and 30 per 100,000 population worldwide. It also represents the most common cause for gastrointestinal hospital...

Complementary medicine: Osteoarthritis

Pain caused by osteoarthritis (OA) is a common presentation in a community pharmacy, with many patients seeking advice on complementary and alternative medicines that...

PSA’s up-to-date COVID-19 advice for pharmacists

As the number of COVID-19 cases continues to rise in Australia, PSA is working to ensure pharmacists’ needs are considered in pandemic planning.

Future health series: pharmacy can adjust the sails

It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series. Most...

Action needed to improve medicine safety in disability care

Barriers to medicine safety show a health system failing to properly support Australians with a disability, a new report from PSA reveals.